GUTS · Fractyl Health, Inc. · Proposed Sales
$0.97
-0.11 (-9.92%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we have concluded that substantial doubt exists about our ability to continue as a going concern for at least one year after the date that these financial statements are issued.”View the 10-Q filed Nov 12, 2026
Market Cap
$12.67M
Shares
13.26M
Volume · Nov 19
223.24K
Avg daily vol (34 sessions)
804.78K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-01-30 | JAY CAPLAN | Officer | 43,818 | 2025-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-30 | HARITH RAJAGOPALAN | Director, Officer | 111,920 | 2025-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-12 | JAY D CAPLAN | Officer | 65,000 | 2024-09-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings
Key facts
CIK
1572616
CUSIP
35168W202
13F (30d)
87 filings
72 filers
Visit website
Investor relations